Partial Wave Spectroscopic Detection of Colon Cancer Risk (Brushings)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01095432|
Recruitment Status : Completed
First Posted : March 30, 2010
Last Update Posted : May 23, 2016
|Condition or disease||Intervention/treatment|
|Ulcerative Colitis Colon Cancer||Procedure: PWS Testing|
|Study Type :||Observational|
|Actual Enrollment :||40 participants|
|Official Title:||Partial Wave Spectroscopic Detection of Colon Cancer Risk|
|Study Start Date :||March 2010|
|Actual Primary Completion Date :||November 2015|
|Actual Study Completion Date :||November 2015|
Main Study Group
All subjects who are undergoing a standard of care colonoscopy for flexible sigmoidoscopy and have a history of UC and agree to participate will be in the main study group.
Procedure: PWS Testing
Partial wave spectroscopy (PWS)has been developed to allow scientists to learn about any changes to the cells that may indicate a risk of developing colon cancer.
- Study samples of rectal mucosa (the moist lining of the rectum) using PWS. [ Time Frame: 1 year ]Samples will be collected and then shipped to Northwestern University for analysis using PWS. This is to assess accuracy of detecting the risk for colon cancer.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01095432
|United States, Illinois|
|University of Chicago, DCAM|
|Chicago, Illinois, United States, 60637|
|Principal Investigator:||David T Rubin, MD||University of Chicago|